Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
The New York Times examines how Saudi Arabia is preparing for the upcoming annual pilgrimage of some "2.5 million people from 160 countries" to Mecca, some who "will be bringing the swine flu. The Saudi authorities, fearing that the hajj could turn their holy city into a petri dish for viral mutations and a hub for spreading a new pandemic wave around the world, are working hard to head that off," the newspaper writes.
The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines.
The Centers for Disease Control and Prevention has released new swine flue estimates that suggest the number of people affected by the disease is much greater than the 43,677 cases confirmed earlier.
A recent survey of nearly 650 athletic trainers across the U.S. revealed that in the past 12 months nearly 76 percent of the respondents' athletic programs, mostly high school- and college-based, bacterial or viral skin infections have developed.
In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies.
Responding to delays in the nationwide distribution H1N1 flu vaccine, Department of Health officials today urged Pennsylvanians to continue to take steps to prevent the spread of illness.
With just 36 hours notice from the Maricopa County Department of Public Health, Mollen Immunization Clinics administered over 14,000 vaccinations to high-risk groups throughout the county, one of the nation's largest with a population of four million residents.
The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease.
The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are currently seeing a significant increase in patients in their Emergency Departments. Children are arriving with mild flu-like symptoms and fever.
Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.
AMERIGROUP Corporation today announced that net income for the third quarter of 2009 was $22.5 million, or $0.43 per diluted share, versus $37.9 million, or $0.71 per diluted share, for the third quarter of 2008. Third quarter earnings are in line with the preliminary earnings range that the Company issued on October 26, 2009, and reflect elevated medical costs associated with the onset of what appears to be a severe flu season due to the H1N1 virus.
Autumn has arrived in the northern hemisphere and with shades of yellow and orange comes a less-welcome visitor: cold and flu season. Made worse this year by the H1N1 (swine flu) pandemic, people around the world are flocking to drugstores and supermarkets to stock up on over-the-counter (OTC) medicine, says market research firm Mintel.
Randy A. Fink, MD says pregnant women ought to be shot – with a flu vaccination needle. “A flu shot offers double protection to both mother and baby,” says Dr. Fink, a Miami board certified specialist who was recently named one of “America's Top Obstetrician/Gynecologists” by the Consumer Research Council.
As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants. In an article appearing in the November 2009 print issue of the FASEB Journal (http://www.fasebj.org) they show that antioxidants-the same substances found in plant-based foods-might hold the key in preventing the flu virus from wreaking havoc on our lungs.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.
Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.
Virtual Pharma Rep™, a new company built by pharmaceutical industry veterans, today announced the release of Virtual Pharma Rep 360 Managed Care. This module builds on the existing Virtual Pharma Rep virtual sales platform of patent pending technology designed to significantly decrease the marketing, sales and educational expenses in the pharmaceutical sales and education process.
The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus.
FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, today announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production.
The Canadian Public Health Association (CPHA) announced today that it is encouraging Canadians to get the H1N1 vaccination. To help people make an informed choice, it is launching a new online portal of information.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.